AMD Instinct MI300X and NVIDIA H100 GPUs were benchmarked in real-world AI-driven drug discovery workloads by IPA Therapeutics and BioStrand using Vultr’s cloud infrastructure
LENSai, the AI platform tested, uses HYFT technology to encode biological sequence, structure, and function for advanced biological reasoning in AI models
The benchmarks focused on NLP tasks, especially RAG for mining scientific literature and accelerating early-stage drug discovery
NLP-driven LLMs help extract insights from genomic databases, clinical reports, and literature, aligning with FDA’s push for computational drug research